113 related articles for article (PubMed ID: 20650753)
1. [Therapeutic features of endostar, a modified endostatin, on ascites tumor in mice].
Wei HM; Qin SK; Yin XJ; Chen YL
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1509-13. PubMed ID: 20650753
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
[TBL] [Abstract][Full Text] [Related]
3. Endostar inhibits ascites formation and prolongs survival in mouse models of malignant ascites.
Wei H; Qin S; Yin X; Chen Y; Hua H; Wang L; Yang N; Chen Y; Liu X
Oncol Lett; 2015 Jun; 9(6):2694-2700. PubMed ID: 26137130
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal infusion of recombinant human endostatin improves prognosis in gastric cancer ascites.
Zhan Z; Wang X; Yu J; Zheng J; Zeng Y; Sun M; Peng L; Guo Z; Chen B
Future Oncol; 2022 Mar; 18(10):1259-1271. PubMed ID: 35114805
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of Endostar combined with β-elemene on malignant ascites in a mouse model.
Jiang ZY; Qin SK; Yin XJ; Chen YL; Zhu L
Exp Ther Med; 2012 Aug; 4(2):277-284. PubMed ID: 23139716
[TBL] [Abstract][Full Text] [Related]
6. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J
Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504
[TBL] [Abstract][Full Text] [Related]
7. [Observation of the antitumor effect of endostar combined with docetaxel under different administration sequences].
Yuan J; Wu CW; Liu ZJ; Wei XY; Li K
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):580-5. PubMed ID: 21122408
[TBL] [Abstract][Full Text] [Related]
8. Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites.
Zhao WY; Chen DY; Chen JH; Ji ZN
Cell Biochem Biophys; 2014 Sep; 70(1):623-8. PubMed ID: 24920191
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of malignant ascites with endostatin adenoviral vector].
Wu Y; Zhao M; Yang L; Liu J; Wei YQ; Zhao X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):316-9. PubMed ID: 15181823
[TBL] [Abstract][Full Text] [Related]
10. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
[TBL] [Abstract][Full Text] [Related]
11. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model.
Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z
Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging.
Zhang Q; Du Y; Xue Z; Chi C; Jia X; Tian J
PLoS One; 2014; 9(1):e85559. PubMed ID: 24416426
[TBL] [Abstract][Full Text] [Related]
14. Clinical observation of Endostar® combined with chemotherapy in advanced colorectal cancer patients.
Xu HX; Huang XE; Qian ZY; Xu X; Li Y; Li CG
Asian Pac J Cancer Prev; 2011; 12(11):3087-90. PubMed ID: 22393994
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of Endostar combined with chemotherapy on human esophageal squamous cell carcinoma xenograft in mice.
Chang L; Guo F; Lv Y; Wang Y; Huo B; Wang L; Liu W
Mol Biol Rep; 2013 Jan; 40(1):669-73. PubMed ID: 23054020
[TBL] [Abstract][Full Text] [Related]
16. Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.
Wen QL; Meng MB; Yang B; Tu LL; Jia L; Zhou L; Xu Y; Lu Y
Cancer Sci; 2009 Aug; 100(8):1510-9. PubMed ID: 19459845
[TBL] [Abstract][Full Text] [Related]
17. Impact of carboplatin plus paclitaxel combined with endostar against A375 melanoma cells: An in vitro and in vivo analysis.
Zheng AW; Jia DD; Xia LM; Jin G; Wu H; Li T
Biomed Pharmacother; 2016 Oct; 83():1321-1326. PubMed ID: 27571875
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human endostatin on peritoneal angiogenesis in peritoneal dialysis rats.
Zhao ZZ; Cao Y; Liu ZS; Xiao J; Tang L; Wang P; Liang XH
Nephrology (Carlton); 2011 Aug; 16(6):599-606. PubMed ID: 21457400
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of endostar in combination with radiotherapy in a mouse model of human CNE2 nasopharyngeal carcinoma.
Zhou N; Hu G; Mei Q; Qiu H; Long G; Chen C; Guoqing H
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):62-66. PubMed ID: 21336725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
